Style | Citing Format |
---|---|
MLA | Shakoori Z, et al.. "Fluorescent Multi-Responsive Cross-Linked P(N-Isopropylacrylamide)-Based Nanocomposites for Cisplatin Delivery." Drug Development and Industrial Pharmacy, vol. 43, no. 8, 2017, pp. 1283-1291. |
APA | Shakoori Z, Ghanbari H, Omidi Y, Pashaiasl M, Akbarzadeh A, Jomeh Farsangi Z, Rezayat SM, Davaran S (2017). Fluorescent Multi-Responsive Cross-Linked P(N-Isopropylacrylamide)-Based Nanocomposites for Cisplatin Delivery. Drug Development and Industrial Pharmacy, 43(8), 1283-1291. |
Chicago | Shakoori Z, Ghanbari H, Omidi Y, Pashaiasl M, Akbarzadeh A, Jomeh Farsangi Z, Rezayat SM, Davaran S. "Fluorescent Multi-Responsive Cross-Linked P(N-Isopropylacrylamide)-Based Nanocomposites for Cisplatin Delivery." Drug Development and Industrial Pharmacy 43, no. 8 (2017): 1283-1291. |
Harvard | Shakoori Z et al. (2017) 'Fluorescent Multi-Responsive Cross-Linked P(N-Isopropylacrylamide)-Based Nanocomposites for Cisplatin Delivery', Drug Development and Industrial Pharmacy, 43(8), pp. 1283-1291. |
Vancouver | Shakoori Z, Ghanbari H, Omidi Y, Pashaiasl M, Akbarzadeh A, Jomeh Farsangi Z, et al.. Fluorescent Multi-Responsive Cross-Linked P(N-Isopropylacrylamide)-Based Nanocomposites for Cisplatin Delivery. Drug Development and Industrial Pharmacy. 2017;43(8):1283-1291. |
BibTex | @article{ author = {Shakoori Z and Ghanbari H and Omidi Y and Pashaiasl M and Akbarzadeh A and Jomeh Farsangi Z and Rezayat SM and Davaran S}, title = {Fluorescent Multi-Responsive Cross-Linked P(N-Isopropylacrylamide)-Based Nanocomposites for Cisplatin Delivery}, journal = {Drug Development and Industrial Pharmacy}, volume = {43}, number = {8}, pages = {1283-1291}, year = {2017} } |
RIS | TY - JOUR AU - Shakoori Z AU - Ghanbari H AU - Omidi Y AU - Pashaiasl M AU - Akbarzadeh A AU - Jomeh Farsangi Z AU - Rezayat SM AU - Davaran S TI - Fluorescent Multi-Responsive Cross-Linked P(N-Isopropylacrylamide)-Based Nanocomposites for Cisplatin Delivery JO - Drug Development and Industrial Pharmacy VL - 43 IS - 8 SP - 1283 EP - 1291 PY - 2017 ER - |